Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GILD

Gilead

$81.74

1.49 (1.86%)

, PFE

Pfizer

$37.18

0.58 (1.58%)

08:33
01/18/18
01/18
08:33
01/18/18
08:33
Hot Stocks
Kite, Pfizer to collaborate to evaluate combination of Yescarta, utomilumab »

Kite, a Gilead Company…

GILD

Gilead

$81.74

1.49 (1.86%)

PFE

Pfizer

$37.18

0.58 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

Wednesday
JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

10:43
01/17/18
01/17
10:43
01/17/18
10:43
Hot Stocks
Juno, CAR-T peers rise after report of potential Celgene deal »

Shares of Juno…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

GILD

Gilead

$80.25

1.23 (1.56%)

BLUE

bluebird bio

$163.35

-7.35 (-4.31%)

BLCM

Bellicum Pharmaceuticals

$8.46

-0.5 (-5.58%)

CLLS

Cellectis

$27.78

-1.54 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 12

    Feb

  • 16

    Feb

  • 26

    Feb

  • 25

    Mar

Tuesday
JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

20:38
01/16/18
01/16
20:38
01/16/18
20:38
Recommendations
Juno Therapeutics, Celgene, Acquired by GILD 9/17, Gilead analyst commentary at Citi »

Juno could be worth $110…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

KITE

Acquired by GILD 9/17

GILD

Gilead

$80.25

1.23 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 12

    Feb

  • 16

    Feb

  • 25

    Mar

MRK

Merck

$61.90

3.24 (5.52%)

, WYNN

Wynn Resorts

$165.54

3.04 (1.87%)

09:55
01/16/18
01/16
09:55
01/16/18
09:55
Options
Early notable gainers among liquid option names on January 16th »

Notable gainers among…

MRK

Merck

$61.90

3.24 (5.52%)

WYNN

Wynn Resorts

$165.54

3.04 (1.87%)

LOW

Lowe's

$102.43

1.574 (1.56%)

DLR

Digital Realty

$108.31

2.53 (2.39%)

GILD

Gilead

$79.02

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 12

    Feb

  • 15

    Feb

  • 18

    Feb

  • 25

    Mar

  • 03

    Apr

  • 23

    Oct

GILD

Gilead

06:09
01/16/18
01/16
06:09
01/16/18
06:09
Upgrade
Gilead rating change at Wells Fargo »

Gilead upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Over a week ago
BAC

Bank of America

$30.27

0.15 (0.50%)

, GILD

Gilead

$78.10

3.7 (4.97%)

07:35
01/10/18
01/10
07:35
01/10/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$30.27

0.15 (0.50%)

GILD

Gilead

$78.10

3.7 (4.97%)

NKE

Nike

$64.09

-0.46 (-0.71%)

LOW

Lowe's

$94.55

0.84 (0.90%)

VIPS

Vipshop

$13.23

-0.35 (-2.58%)

TJX

TJX

$75.50

-0.15 (-0.20%)

BSX

Boston Scientific

$27.96

2.15 (8.33%)

KKR

KKR

$22.67

0.64 (2.91%)

WEN

Wendy's

$17.34

0.72 (4.33%)

ZNGA

Zynga

$3.88

-0.03 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 11

    Jan

  • 17

    Jan

  • 01

    Feb

  • 12

    Feb

  • 15

    Feb

  • 26

    Feb

JUNO

Juno Therapeutics

$47.71

-0.38 (-0.79%)

, NVS

Novartis

$85.42

0.08 (0.09%)

08:25
01/05/18
01/05
08:25
01/05/18
08:25
Initiation
Juno Therapeutics, Novartis, Gilead initiated at Needham »

Juno Therapeutics…

JUNO

Juno Therapeutics

$47.71

-0.38 (-0.79%)

NVS

Novartis

$85.42

0.08 (0.09%)

GILD

Gilead

$73.90

-0.76 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 08

    Jan

  • 08

    Jan

  • 18

    Jan

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 17

    May

PFE

Pfizer

$36.71

0.27 (0.74%)

, AGN

Allergan

$170.14

-0.18 (-0.11%)

06:26
01/04/18
01/04
06:26
01/04/18
06:26
Periodicals
Drugmakers raise prices on over a thousand U.S. products, FT reports »

Drugmakers have…

PFE

Pfizer

$36.71

0.27 (0.74%)

AGN

Allergan

$170.14

-0.18 (-0.11%)

GSK

GlaxoSmithKline

$36.79

-0.14 (-0.38%)

GILD

Gilead

$74.66

0.56 (0.76%)

SHPG

Shire

$158.25

-0.96 (-0.60%)

BIIB

Biogen

$339.85

5.68 (1.70%)

TEVA

Teva

$19.13

0.02 (0.10%)

BAX

Baxter

$68.25

1.08 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 06

    Jan

  • 08

    Jan

  • 08

    Jan

  • 25

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 26

    Feb

  • 25

    Mar

Over a month ago
BIIB

Biogen

$327.02

1.07 (0.33%)

, GILD

Gilead

$74.35

-0.78 (-1.04%)

10:58
12/20/17
12/20
10:58
12/20/17
10:58
Hot Stocks
Credit Suisse more bullish on Biogen, concerned about high Gilead expectations »

In a research note to…

BIIB

Biogen

$327.02

1.07 (0.33%)

GILD

Gilead

$74.35

-0.78 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

BIIB

Biogen

$327.02

1.07 (0.33%)

, GILD

Gilead

$74.35

-0.78 (-1.04%)

06:14
12/20/17
12/20
06:14
12/20/17
06:14
Upgrade
Biogen, Gilead rating change at Credit Suisse »

Credit Suisse upgrades…

BIIB

Biogen

$327.02

1.07 (0.33%)

GILD

Gilead

$74.35

-0.78 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.